National Jewish Health has a 100-year history of caring for patients with tuberculosis (TB). Over the decades we have been committed to not only caring for patients with TB but also to the scientific discovery of new drugs used to treat this disease. We are also actively involved in scientific research involving the transmission and basic biology of this organism.


Our Facility

Our facility is the premier facility in the United States dedicated to the treatment of patients with multidrug-resistant tuberculosis (MDR-TB) and those with drug-sensitive TB who are experiencing complications with therapy. We have a comprehensive treatment facility, which includes a multidisciplinary approach to disease management. Our mycobacteriology lab and pharmacokinetics laboratory assist our clinical management team in choosing appropriate antibiotics and managing dosing regimens to minimize drug side-effects and toxicity which are common with the drugs used in MDR-TB cases.



Many patients with TB or MDR-TB also require surgical resection and this is performed at our sister institution, University of Colorado Denver. Dr. John Mitchell head up our surgical team of experts if surgical intervention is necessary.


Referrals and Consultations 

If you would like to refer a patient to National Jewish Health for treatment of TB, you may request a consult or refer a patient online using the Mycobacterial Referral/Consult form. Consultation is available for healthcare professionals only.


Related Programs


Clinical Trials

Tuberculosis Testing for Healthy Adults

Researchers are developing a new test to see if healthy adults could have latent, or inactive, tuberculosis.

Learn More

Reasons to Choose National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 6 percent of organizations funded for research by the NIH, providing patients access to more than 300 active clinical trials
  • 121-year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders